---
title: "CSPC Pharmaceutical Group: AstraZeneca licence income and finished-drug growth lifted 9M revenue 27% and profit 101.5%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/305912711.md"
description: "9M revenue grew 27.0% and reported profit attributable to shareholders rose 101.5%, supported by finished-drug sales and AstraZeneca licence income. Bulk products and functional food declined amid price, competition and procurement pressures.Original document: CSPC Pharmaceutical Group Limited [1093] Earnings Release — Nov. 18 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-11-18T04:14:32.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/305912711.md)
  - [en](https://longbridge.com/en/news/305912711.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/305912711.md)
generator: "portal-rs"
---

# CSPC Pharmaceutical Group: AstraZeneca licence income and finished-drug growth lifted 9M revenue 27% and profit 101.5%

9M revenue grew 27.0% and reported profit attributable to shareholders rose 101.5%, supported by finished-drug sales and AstraZeneca licence income. Bulk products and functional food declined amid price, competition and procurement pressures.

Original document: CSPC Pharmaceutical Group Limited \[1093\] Earnings Release — Nov. 18 2026

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [01093.HK](https://longbridge.com/en/quote/01093.HK.md)
- [AZN.UK](https://longbridge.com/en/quote/AZN.UK.md)
- [AZN.US](https://longbridge.com/en/quote/AZN.US.md)

## Related News & Research

- [CSPC Pharmaceutical Group: Revenue, licensing income and pipeline milestones advanced alongside a 73.6% 1-9M gross margin](https://longbridge.com/en/news/305926514.md)
- [CSPC Starts Phase I/II Trial of SYS6055 for B-Cell Non-Hodgkin Lymphoma in China](https://longbridge.com/en/news/304626206.md)
- [Alibaba Q2 revenue rises on AI Cloud and Compute Services strength](https://longbridge.com/en/news/306100634.md)
- [The bank of Nvidia is getting more ‘disciplined,’ selective](https://longbridge.com/en/news/306148745.md)
- [NetEase Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into NetEase (NTES)](https://longbridge.com/en/news/306200520.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**